News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|April 21, 2017

Deciding Among Therapies for Ovarian Cancer

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Image of ovaries.

Imfinzi Combo Improves Progression Free Survival in Ovarian Cancer

ByKyle Doherty
October 19th 2025
ovarian cancer

Keytruda Combo Improves Progression, Survival in Recurrent Ovarian Cancer

ByTim Cortese
October 18th 2025
Image of ovaries.

FDA Grants Breakthrough Status to Raludotatug Deruxtecan in Ovarian Cancer

BySpencer Feldman
September 15th 2025
Image of ovary.

FDA Accepts New Drug Application for Relacorilant in Ovarian Cancer

ByAlex Biese
September 11th 2025
Image of man with text.

An Expert Discusses Ovarian Cancer Basics, From Staging to Treatment

ByAlex Biese
September 2nd 2025
Advertisement
Advertisement

Trending on CURE

1

Sacituzumab Tirumotecan Improves Survival in EGFR-Mutated Non-Small Cell Lung Cancer

2

Cancer Vaccine Plus Keytruda Slow Advanced Melanoma Progression

3

Facing Mortality After Cancer, and Choosing to Live Fully

4

ADC Use Rapidly Growing in Metastatic Breast Cancer Treatment

5

Enhertu Plus Perjeta Boosts Survival in HER2-Positive Breast Cancer

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.